Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.

Hollands GJ, Armstrong D, Macfarlane A, Crook MA, Marteau TM.

BMC Med Genet. 2012 Sep 21;13:87. doi: 10.1186/1471-2350-13-87.

2.

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA.

Health Technol Assess. 2000;4(29):1-123. Review.

3.

Individuals' experiences of, and responses to, a negative genetic test result for familial hypercholesterolaemia.

Hilgart J, Mercer J, Thirlaway K.

J Health Psychol. 2013 Mar;18(3):339-49. doi: 10.1177/1359105312443403. Epub 2012 Apr 19.

PMID:
22517949
4.

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.

Haralambos K, Whatley SD, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta DB, McDowell IF.

Atherosclerosis. 2015 May;240(1):190-6. doi: 10.1016/j.atherosclerosis.2015.03.003. Epub 2015 Mar 6.

PMID:
25797312
5.

Genetic unexceptionalism: clinician accounts of genetic testing for familial hypercholesterolaemia.

Will CM, Armstrong D, Marteau TM.

Soc Sci Med. 2010 Sep;71(5):910-7. doi: 10.1016/j.socscimed.2010.05.018. Epub 2010 Jun 4.

PMID:
20591544
6.

Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.

Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE.

Heart. 2011 Jul;97(14):1175-81. doi: 10.1136/hrt.2010.213975.

PMID:
21685482
7.

Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.

Bell DA, Pang J, Burrows S, Bates TR, van Bockxmeer FM, Hooper AJ, O'Leary P, Burnett JR, Watts GF.

Atherosclerosis. 2015 Mar;239(1):93-100. doi: 10.1016/j.atherosclerosis.2014.12.036. Epub 2014 Dec 23.

PMID:
25585028
8.

Genetic testing for familial hypercholesterolaemia: practical and ethical issues.

Humphries SE, Galton D, Nicholls P.

QJM. 1997 Mar;90(3):169-81. Review.

PMID:
9093594
9.

Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.

Homsma SJ, Huijgen R, Middeldorp S, Sijbrands EJ, Kastelein JJ.

Eur J Hum Genet. 2008 Jan;16(1):14-7. Epub 2007 Oct 24. Erratum in: Eur J Hum Genet. 2008 Feb;16(2):275.

10.

Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner.

Bell DA, Hooper AJ, Edwards G, Southwell L, Pang J, van Bockxmeer FM, Watts GF, Burnett JR.

Atherosclerosis. 2014 Jun;234(2):469-72. doi: 10.1016/j.atherosclerosis.2014.04.002. Epub 2014 Apr 14.

PMID:
24814411
11.

What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?

Humphries SE, Norbury G, Leigh S, Hadfield SG, Nair D.

Curr Opin Lipidol. 2008 Aug;19(4):362-8. doi: 10.1097/MOL.0b013e32830636e5. Review.

PMID:
18607183
12.

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.

Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ; International Familial Hypercholesterolemia Foundation.

Eur J Prev Cardiol. 2015 Jul;22(7):849-54. doi: 10.1177/2047487314533218. Epub 2014 Apr 28. Review.

PMID:
24776375
13.

Can patients be accurately assessed for familial hypercholesterolaemia in primary care?

Bell DA, Kirke AB, Barbour R, Southwell L, Pang J, Burrows S, Watts GF.

Heart Lung Circ. 2014 Dec;23(12):1153-7. doi: 10.1016/j.hlc.2014.06.015. Epub 2014 Jul 5.

PMID:
25065543
14.

Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.

Diakou M, Miltiadous G, Xenophontos SL, Manoli P, Cariolou MA, Elisaf M.

Eur J Intern Med. 2011 Oct;22(5):e55-9. doi: 10.1016/j.ejim.2011.01.003. Epub 2011 Feb 11.

PMID:
21925044
15.

Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective.

Laurie AD, Scott RS, George PM.

Atheroscler Suppl. 2004 Dec;5(5):13-5.

PMID:
15556094
16.

Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.

Hardcastle SJ, Legge E, Laundy CS, Egan SJ, French R, Watts GF, Hagger MS.

Int J Behav Med. 2015 Feb;22(1):92-100. doi: 10.1007/s12529-014-9402-x.

PMID:
24585182
17.

[Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians].

ten Asbroek AH, van Lunsen S, Marang-van de Mheen PJ, Gunning-Schepers LJ.

Ned Tijdschr Geneeskd. 2000 Jan 15;144(3):125-9. Dutch.

PMID:
10674119
19.

Improved access to life insurance after genetic diagnosis of familial hypercholesterolaemia: cross-sectional postal questionnaire study.

Huijgen R, Homsma SJ, Hutten BA, Kindt I, Vissers MN, Kastelein JJ, van Rijckevorsel JL.

Eur J Hum Genet. 2012 Jul;20(7):722-8. doi: 10.1038/ejhg.2012.5. Epub 2012 Feb 1.

20.

Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review.

Muir LA, George PM, Whitehead L.

J Adv Nurs. 2012 Sep;68(9):1920-32. doi: 10.1111/j.1365-2648.2012.05957.x. Epub 2012 Feb 20. Review.

PMID:
22348692

Supplemental Content

Support Center